Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares were down 3.8% on Tuesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The stock’s fifty day moving average price is C$0.26 and its two-hundred day moving average price is C$0.26. The firm has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- Which Wall Street Analysts are the Most Accurate?
- Hasbro’s Management Made All the Right Calls This Quarter
- Where to Find Earnings Call Transcripts
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
